AKT1 and ulcerative colitis: Network pharmacology analysis predicted PM’s interaction with ulcerative colitis (UC) targets primarily through modulation of PI3K-AKT and JAK-STAT signaling pathways (Figure S6), prompting further mechanistic investigation.